epocrates
Eli Lilly launches a direct-to-consumer website for weight-loss drugs
Eli Lilly and Co, the maker of anti-obesity medicine Zepbound, said last week that it has launched a new telehealth site, called LillyDirect, to pair visitors with third-party, mail-order pharmacies for prescriptions and to care providers through a virtual medical weight-loss clinic.
Company CEO David Ricks said that “the new platform will make it easier for patients to access the [anti-obesity] drugs, cutting out the need to go to the doctor to get a prescription and then to a pharmacy to fill it. Patients who are prescribed Zepbound will be eligible for Lilly’s at-home prescription delivery service.”
Reuters reports that the obesity drug market is forecast to grow to about $100 billion by the end of the decade.
Sources:
Lovelace Jr, B, Vespa, M, and Herzberg, J. (2024, January 4). NBC News. https://www.nbcnews.com/health/health-news/weight-loss-drug-online-website-eli-lilly-rcna131597
(2024, January 4). Reuters. Lilly launches website, home delivery option for weight-loss drug. https://www.reuters.com/business/healthcare-pharmaceuticals/lilly-says-it-stands-against-cosmetic-use-its-weight-loss-drugs-2024-01-04/